Your Messages Inbox
Your Article Summary
See Latest ArticlesStrativa pharmaceuticals’ development partner, bioalliance pharma, presents phase iii study results of miconazole lauriad
Par Pharmaceutical, 09/15/09
Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc., announced that its development partner BioAlliance Pharma SA presented Phase III study results for miconazole Lauriad mucoadhesive buccal tablets that demonstrate noninferiority to clotrimazole troches for oropharyngeal candidiasis, an opportunistic infection of the mouth and throat.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09
Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR
Mylan, 12/09/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Important progress in treatment of early and late stage breast cancer with Herceptin, Avastin and T-DM1
Roche, 12/10/09
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09
Article Search
Sponsor